Interspecies pharmacokinetic modeling of subcutaneous absorption of rituximab in mice and rats.
about
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice.
P2860
Interspecies pharmacokinetic modeling of subcutaneous absorption of rituximab in mice and rats.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@en
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@nl
type
label
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@en
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@nl
prefLabel
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@en
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@nl
P2093
P2860
P1476
Interspecies pharmacokinetic m ...... of rituximab in mice and rats.
@en
P2093
Donald E Mager
Leonid Kagan
P2860
P304
P356
10.1007/S11095-014-1416-1
P577
2014-05-23T00:00:00Z